Volume 24; Issue 3 Suppleme

Main
PharmacoEconomics
Volume 24; Issue 3 Suppleme

PharmacoEconomics

Volume 24; Issue 3 Suppleme

1

Medicaid Preferred Drug Lists: Cost Containment and Side Effects

Alvin E. Headen Jr

Journal:

PharmacoEconomics

Year:

2006

Language:

english

File:

PDF, 84 KB

english, 2006

2

The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003

Frank R. Lichtenberg

Journal:

PharmacoEconomics

Year:

2006

Language:

english

File:

PDF, 239 KB

english, 2006

3

Which Physicians are Affected Most by Medicaid Preferred Drug Lists for Statins and Antihypertensives?

Jonathan D. Ketcham,Andrew J. Epstein

Journal:

PharmacoEconomics

Year:

2006

Language:

english

File:

PDF, 179 KB

english, 2006

4

Effects of Medicaid Access Restrictions on Statin Utilisation for Patients Treated by Physicians Practising in Poor and Minority Neighbourhoods

Alvin E. Headen Jr,Neal A. Masia,Kirsten J. Axelsen

Journal:

PharmacoEconomics

Year:

2006

Language:

english

File:

PDF, 163 KB

english, 2006

5

Preferred Drug Lists and Medicaid Prescriptions

Tamer Abdelgawad,Lisa Egbuonu-Davis

Journal:

PharmacoEconomics

Year:

2006

Language:

english

File:

PDF, 144 KB

english, 2006

6

Impact of Medicaid Preferred Drug Lists on Therapeutic Adherence

David B. Ridley,Kirsten J. Axelsen

Journal:

PharmacoEconomics

Year:

2006

Language:

english

File:

PDF, 190 KB

english, 2006

7

Per-patient-per-month Drug Costs in Medicare Part D Protected Classes

Lisa Mucha PhD,Neal A. Masia,Kirsten J. Axelsen

Journal:

PharmacoEconomics

Year:

2006

Language:

english

File:

PDF, 118 KB

english, 2006